- Home
- AUTL vs SLQT Comparison
AUTL vs SLQT Comparison
Compare AUTL & SLQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUTL | SLQT |
|---|---|---|
| Founded | 2014 | 1985 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 72.4M |
| IPO Year | 2025 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AUTL | SLQT |
|---|---|---|
| Price | $1.83 | $0.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 4 |
| Target Price | ★ $8.73 | $2.13 |
| AVG Volume (30 Days) | ★ 1.4M | 855.7K |
| Earning Date | 11-11-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $10,120,000.00 | ★ $1,618,499,000.00 |
| Revenue This Year | $98.68 | N/A |
| Revenue Next Year | $28.47 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 496.00 | 6.02 |
| 52 Week Low | $1.18 | $0.38 |
| 52 Week High | $2.58 | $2.22 |
Technical Indicators
Market Signals| Indicator | AUTL | SLQT |
|---|---|---|
| Relative Strength Index (RSI) | 40.50 | 34.95 |
| Support Level | $1.37 | N/A |
| Resistance Level | $1.92 | $0.79 |
| Average True Range (ATR) | 0.09 | 0.03 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 25.76 | 31.29 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
About SLQT SelectQuote Inc.
SelectQuote Inc is a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. Its insurance distribution business allows consumers to transparently and conveniently shop for senior health, life, and automobile and home insurance policies from a curated panel of the nation's insurance carriers. It operates in three reportable segments: Senior, Healthcare Services, and Life. Senior sells senior Medicare-related health insurance products. Healthcare Services includes SelectRx, Healthcare Select, and SPM. Healthcare Services provides products and services to its Medicare policyholders, which are focused on improving patient health outcomes. Life sells term life and final expense products.